633390028	633390028	CD	B-NP	O
|	|	NN	I-NP	O
LCHH	LCHH	NN	I-NP	O
|	|	NN	I-NP	O
00682171	00682171	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0305075	0305075	CD	B-NP	O
|	|	CC	I-NP	O
10/26/2006	10/26/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2006	10/11/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/25/2006	7/25/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SOLTANI	SOLTANI	NNP	B-NP	O
,	,	,	O	O
LEON	LEON	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Methicillin	Methicillin	NN	B-NP	O
sensitive	sensitive	JJ	I-NP	O
Staphylococcus	Staphylococcus	FW	I-NP	O
aureus	aureus	FW	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
PROBLEMS	PROBLEMS	NNS	I-NP	O
AND	AND	CC	I-NP	O
CONDITIONS	CONDITIONS	NNS	I-NP	O
TREATED	TREATED	VBN	B-VP	O
:	:	:	O	O
LGL	LGL	NN	B-NP	O
NKA	NKA	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
with	with	IN	B-PP	O
pancytopenia	pancytopenia	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
genital	genital	JJ	B-NP	O
herpes	herpes	NN	I-NP	O
,	,	,	O	O
PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Seligson	Seligson	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
88-year-old	88-year-old	JJ	I-NP	O
Italian-speaking	Italian-speaking	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
granulocytic	granulocytic	JJ	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
pancytopenia	pancytopenia	NN	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
transfusion	transfusion	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
herpes	herpes	NN	I-NP	O
infection	infection	NN	I-NP	O
undergoing	undergo	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
famciclovir	famciclovir	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
to	to	TO	B-PP	O
systolic	systolic	JJ	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
fever	fever	NN	B-NP	O
without	without	IN	B-PP	O
neutropenia	neutropenia	NN	B-NP	O
later	later	RB	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MSSA	MSSA	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Fentanyl	Fentanyl	NN	B-NP	O
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
GI	GI	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
vomiting	vomit	VBG	I-VP	O
and	and	CC	O	O
Percocet	Percocet	NNP	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
98.4	98.4	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
BP	BP	NN	I-NP	O
of	of	IN	B-PP	O
143/64	143/64	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
post	post	JJ	B-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
packs	pack	NNS	I-NP	O
of	of	IN	B-PP	O
platelets	platelet	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
presented	present	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
initial	initial	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
146	146	CD	B-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
diastolic	diastolic	NN	I-NP	O
of	of	IN	B-PP	O
91	91	CD	B-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
dropped	drop	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ceftazidime	ceftazidime	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
her	her	PRP$	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
otherwise	otherwise	RB	I-NP	O
normal	normal	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
expiratory	expiratory	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
focal	focal	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
erythema	erythema	NN	B-NP	O
and	and	CC	I-NP	O
induration	induration	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	B-DNA
former	former	JJ	I-NP	I-DNA
PICC	PICC	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
131	131	NN	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
4.9	4.9	CD	B-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
63/2	63/2	CD	B-NP	O
.9	.9	CD	I-NP	O
up	up	IN	B-ADVP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
4.5	4.5	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
23.7	23.7	CD	B-NP	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
2-4	2-4	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

An	An	DT	B-NP	O
admission	admission	NN	I-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
and	and	CC	O	O
T-wave	T-wave	NN	B-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
AVF	AVF	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
right-sided	right-sided	JJ	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
lung	lung	NN	I-NP	O
volumes	volume	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
or	or	CC	I-NP	O
fusion	fusion	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
1/26/06	1/26/06	CD	B-NP	O
:	:	:	O	O
PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

1/26/06	1/26/06	CD	B-NP	O
:	:	:	O	O
CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

2/3/06	2/3/06	CD	B-NP	O
:	:	:	O	O
Right	Right	RB	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
Doppler	Doppler	NNP	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
x-rays	x-ray	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
6/20/06	6/20/06	CD	B-NP	O
,	,	,	I-NP	O
03	03	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
Based	Base	VBN	B-VP	O
on	on	IN	B-PP	O
blood	blood	NN	B-NP	O
culture	culture	NN	I-NP	O
results	result	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MSSA	MSSA	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
broad-spectrum	broad-spectrum	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
to	to	TO	B-VP	O
initially	initially	RB	I-VP	O
include	include	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
agent	agent	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
further	further	RBR	I-VP	O
tapered	taper	VBN	I-VP	O
to	to	TO	B-PP	O
naphthalene	naphthalene	NN	B-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tapered	taper	VBN	I-VP	O
finally	finally	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Ancef	Ancef	NN	B-NP	O
dosed	dose	VBN	B-VP	O
at	at	IN	B-PP	O
0.5	0.5	CD	B-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
last	last	JJ	I-NP	I-cell_line
positive	positive	JJ	I-NP	I-cell_line
blood	blood	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
2/10/06	2/10/06	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Ancef	Ancef	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
thereafter	thereafter	RB	B-VP	O
setting	set	VBG	I-VP	O
an	an	DT	B-NP	O
end	end	NN	I-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
5/2/06	5/2/06	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
completed	complete	VBD	B-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
famciclovir	famciclovir	NN	B-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
genital	genital	JJ	B-NP	O
herpetic	herpetic	JJ	I-NP	O
infection	infection	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
the	the	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
and	and	CC	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
data	datum	NNS	I-NP	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
showed	show	VBD	B-VP	O
yeast	yeast	NN	B-NP	O
only	only	RB	B-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
intermittently	intermittently	RB	I-VP	O
placed	place	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
stay	stay	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
believed	believe	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
coming	come	VBG	B-VP	O
in	in	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
electively	electively	RB	B-ADJP	O
fluid	fluid	JJ	I-ADJP	O
resuscitated	resuscitate	VBN	B-VP	O
and	and	CC	O	O
actually	actually	RB	B-VP	O
went	go	VBD	I-VP	O
into	into	IN	B-PP	O
mild	mild	JJ	B-NP	O
hypervolemia	hypervolemia	NN	I-NP	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
findings	finding	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
initially	initially	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
thereafter	thereafter	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
status	status	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
reinstated	reinstate	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
substitutions	substitution	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
was	be	VBD	B-VP	O
substituted	substitute	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
dictated	dictate	VBN	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
doxazosin	doxazosin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
the	the	DT	B-NP	O
62.5	62.5	CD	I-NP	O
mg	mg	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
converted	convert	VBN	I-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
normalizes	normalize	VBZ	B-VP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
and	and	CC	I-NP	O
ARBs	ARBs	NNP	I-NP	B-protein
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
allergies	allergy	NNS	B-NP	O
but	but	CC	O	O
additional	additional	JJ	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
medications	medication	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
indicated	indicate	VBN	I-VP	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
pressure	pressure	NN	I-NP	O
remains	remain	VBZ	B-VP	O
elevated	elevated	JJ	B-ADJP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
alteration	alteration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NNP	B-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
discharge	discharge	VBP	B-VP	O
weight	weight	NN	B-NP	O
is	be	VBZ	B-VP	O
71.1	71.1	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
titrated	titrate	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Although	Although	IN	B-SBAR	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
cough	cough	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
posterior	posterior	JJ	I-NP	I-protein
rib	rib	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
skin	skin	NN	I-NP	O
or	or	CC	I-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
on	on	IN	B-PP	O
5/5/06	5/5/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
favoring	favor	VBG	B-VP	O
atelectasis	atelectasis	NN	B-NP	O
but	but	CC	B-PP	O
not	not	RB	O	O
impossible	impossible	JJ	B-ADJP	O
to	to	TO	B-VP	O
represent	represent	VB	I-VP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
tiny	tiny	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
bilaterally	bilaterally	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
tiny	tiny	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
calcified	calcify	VBN	I-NP	O
right	right	JJ	I-NP	O
apical	apical	JJ	I-NP	O
node	node	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
enlarged	enlarge	VBN	I-NP	O
left	leave	VBD	B-VP	O
thyroid	thyroid	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
extension	extension	NN	B-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
sternum	sternum	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
rib	rib	NN	B-NP	O
fracture	fracture	NN	I-NP	O
or	or	CC	O	O
soft	soft	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
CAT	CAT	NN	I-NP	B-protein
scan	scan	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
symptom	symptom	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
unclear	unclear	JJ	B-ADJP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lidoderm	Lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

standing	stand	VBG	B-VP	O
with	with	IN	B-PP	O
only	only	JJ	B-NP	O
modest	modest	JJ	I-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
other	other	JJ	B-NP	O
narcotics	narcotic	NNS	I-NP	O
and	and	CC	I-NP	O
NSAIDS	NSAIDS	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
allergies	allergy	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
further	further	RBR	B-ADJP	O
evaluated	evaluate	VBN	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

Hematology/oncology	Hematology/oncology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
LGL	LGL	NN	B-NP	O
NK	NK	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
transfusions	transfusion	NNS	B-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
22	22	CD	I-NP	O
and	and	CC	I-NP	O
platelet	platelet	NN	I-NP	O
scales	scale	NNS	I-NP	O
were	be	VBD	B-VP	O
set	set	VBN	I-VP	O
as	as	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
GCSF	GCSF	NN	B-NP	B-protein
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
her	her	PRP$	B-NP	O
Neulasta	Neulasta	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	B-cell_line
upper	upper	JJ	I-NP	I-cell_line
extremity	extremity	NN	I-NP	I-cell_line
PICC	PICC	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
5/5/06	5/5/06	CD	B-NP	O
and	and	CC	O	O
confirmed	confirm	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
tip	tip	NN	I-NP	O
projecting	project	VBG	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
superior	superior	JJ	I-NP	O
vena	vena	NN	I-NP	O
cava	cava	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.9	2.9	CD	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
hydration	hydration	NN	I-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
at	at	IN	B-PP	O
1.9-2	1.9-2	CD	B-NP	O
stably	stably	RB	I-NP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
managed	manage	VBD	B-VP	O
on	on	IN	B-PP	O
Glucotrol	Glucotrol	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
insulin	insulin	NN	I-NP	O
aspartate	aspartate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
optimally	optimally	RB	B-VP	O
controlled	control	VBN	I-VP	O
but	but	CC	O	O
more	more	RBR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
attempts	attempt	NNS	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
best	best	RB	B-ADVP	O
to	to	TO	B-PP	O
air	air	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
200s	200	NNS	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
transient	transient	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
incidental	incidental	JJ	I-NP	O
finding	finding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
thyroid	thyroid	NN	I-NP	O
lobe	lobe	NN	I-NP	O
enlargement	enlargement	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
collaboration	collaboration	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
projection	projection	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
retrosternal	retrosternal	JJ	I-NP	O
space	space	NN	I-NP	O
may	may	MD	B-VP	O
preclude	preclude	VB	I-VP	O
most	most	JJS	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
97.2	97.2	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
71-93	71-93	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
130-150/57	130-150/57	CD	B-NP	O
-80	-80	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
-99	-99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
showing	show	VBG	B-VP	O
minimal	minimal	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
showing	show	VBG	B-VP	O
obese	obese	JJ	B-NP	O
abdomen	abdoman	NNS	I-NP	O
with	with	IN	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
but	but	CC	O	O
otherwise	otherwise	RB	B-ADJP	O
benign	benign	JJ	I-ADJP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
nontender	nontender	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
resolving	resolve	VBG	B-VP	O
induration	induration	NN	B-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingerstick	fingerstick	JJ	I-NP	O
glucose	glucose	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
91	91	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
labs	lab	NNS	I-NP	O
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
4.2	4.2	CD	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
136	136	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
repleted	replete	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
22.5	22.5	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
13	13	CD	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
lymphs	lymph	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
%	%	NN	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
standing	stand	VBG	B-VP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	B-protein
chest	chest	NN	I-NP	I-protein
wall	wall	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
diminishes	diminish	VBZ	B-VP	O
,	,	,	O	O
Ben-Gay	Ben-Gay	NNP	B-NP	O
topical	topical	JJ	I-NP	O
apply	apply	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
back/right	back/right	JJ	B-NP	O
flank	flank	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
,	,	,	O	O
Ancef	Ancef	IN	B-ADVP	O
0.5	0.5	CD	B-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
5/2/06	5/2/06	CD	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
62.5	62.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
four	four	CD	B-ADVP	O
times	time	NNS	I-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
doxazosin	doxazosin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lidoderm	Lidoderm	NNP	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
patch	patch	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
must	must	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
12	12	CD	I-NP	O
off	off	IN	B-PP	O
period	period	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
application	application	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
aspartate	aspartate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
pre-meal	pre-meal	JJ	B-ADJP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
,	,	,	O	O
Spectazole	Spectazole	NN	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
upset	upset	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
and	and	CC	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Worth	Worth	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Bernard	Bernard	NNP	I-NP	O
Winge	Winge	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
oncologist	oncologist	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
notified	notify	VBN	I-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Rufus	Rufus	NNP	B-NP	O
Kelderman	Kelderman	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
468-946-1419	468-946-1419	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-7676444	7-7676444	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
POUNCEY	POUNCEY	NNP	B-NP	O
,	,	,	O	O
MALCOLM	MALCOLM	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BUTTLER	BUTTLER	NNP	B-NP	O
,	,	,	O	O
DEVIN	DEVIN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4941901	4941901	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/25/06	3/25/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/25/06	3/25/06	CD	B-NP	O

